RANDOMIZED TRIAL OF EMPIRIC ANTIBIOTIC-THERAPY WITH TICARCILLIN IN COMBINATION WITH GENTAMICIN, AMIKACIN OR NETILMICIN IN FEBRILE PATIENTS WITH GRANULOCYTOPENIA AND CANCER

被引：100
|
作者：
LOVE, LJ
SCHIMPFF, SC
HAHN, DM
YOUNG, VM
STANDIFORD, HC
BENDER, JF
FORTNER, CL
WIERNIK, PH
机构：
[1] UNIV MARYLAND HOSP,BALTIMORE CANC RES CTR,NCI,CLIN ONCOL BRANCH,BALTIMORE,MD 21201
[2] UNIV MARYLAND,SCH MED,BALTIMORE,MD 21201
[3] VET ADM HOSP,DEPT MED,DIV INFECT DIS,BALTIMORE,MD 21218
来源：
AMERICAN JOURNAL OF MEDICINE | 1979年 / 66卷 / 04期
关键词：
D O I：
10.1016/0002-9343(79)91170-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：603 / 610
页数：8
相关论文
共 50 条
  • [41] CEFTAZIDIME PLUS TEICOPLANIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN CANCER PATIENTS WITH GRANULOCYTOPENIA
    MEUNIER, F
    VANDERAUWERA, P
    AOUN, M
    BRON, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 : 49 - 53
  • [42] TREATMENT OF INTERSTITIAL PNEUMONIA IN CANCER-PATIENTS - IS EMPIRIC ANTIBIOTIC-THERAPY THE ANSWER
    BUSTAMANTE, CI
    WADE, JC
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) : 200 - 202
  • [43] ANTIBIOTIC-THERAPY OF THE FEBRILE CANCER-PATIENTS IN GENERAL-PRACTICE
    KLEEBERG, UR
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1984, 126 (17): : 525 - 529
  • [44] Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia
    Tamura, K
    Imajo, K
    Akiyama, N
    Suzuki, K
    Urabe, A
    Ohyashiki, K
    Tanimoto, M
    Masaoka, T
    CLINICAL INFECTIOUS DISEASES, 2004, 39 : S15 - S24
  • [45] TEICOPLANIN FOR EMPIRIC COMBINED ANTIBIOTIC-THERAPY IN FEBRILE GRANULOCYTOPENIC PATIENTS - MULTICENTER OPEN TRIAL - PRELIMINARY-ANALYSIS OF RESULTS IN 614 TREATED PATIENTS
    GUAGLIANONE, MH
    BACHINI, V
    MOSCONI, G
    DRAGONETTI, C
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 173 - 174
  • [46] RANDOMIZED TRIAL OF 3 EMPIRICAL ANTIBIOTIC REGIMENS IN PATIENTS WITH FEBRILE NEUTROPENIA - IMIPENEM-CILASTATIN, CEFTAZIDIME-VANCOMYCIN, AND TICARCILLIN-VANCOMYCIN-AMIKACIN
    BOSSERAY, A
    NICOLINI, F
    BRION, JP
    MICHALLET, M
    HOLLARD, D
    STAHL, JP
    MICOUD, M
    PATHOLOGIE BIOLOGIE, 1992, 40 (08): : 797 - 804
  • [47] CHANGES IN ENDOGENOUS MICROFLORA AMONG FEBRILE GRANULOCYTOPENIC PATIENTS RECEIVING EMPIRIC ANTIBIOTIC-THERAPY - IMPLICATIONS FOR FUNGAL SUPERINFECTION
    BOW, EJ
    LOUIE, TJ
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1987, 137 (05) : 397 - 403
  • [48] AZTREONAM PLUS VANCOMYCIN (PLUS AMIKACIN) VS MOXALACTAM PLUS TICARCILLIN FOR THE EMPIRIC TREATMENT OF FEBRILE EPISODES IN NEUTROPENIC CANCER-PATIENTS
    JONES, P
    ROLSTON, K
    FAINSTEIN, V
    ELTING, L
    BODEY, GP
    REVIEWS OF INFECTIOUS DISEASES, 1985, 7 : S741 - S746
  • [49] Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients
    Laszlo, D
    Bacci, S
    Bosi, A
    Fanci, R
    Guidi, S
    Saccardi, R
    Vannucchi, AM
    Ferrini, PR
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (02) : 95 - 101
  • [50] COMPARATIVE TRIAL OF CEFTAZIDIME ALONE, CEFTAZIDIME + AMIKACIN AND CEFTAZIDIME + VANCOMYCIN AS EMPIRIC THERAPY OF FEBRILE CANCER-PATIENTS WITH INDUCED PROLONGED NEUTROPENIA
    MARIE, JP
    PICO, J
    LAPIERRE, V
    MAULARD, C
    PAPPO, M
    CHICHE, D
    ANDREMONT, A
    LAGRANGE, P
    HAYAT, M
    ZITTOUN, R
    MEDECINE ET MALADIES INFECTIEUSES, 1991, 21 (07): : 386 - 388
12345